Loading Events
  • This event has passed.

Part 2: The Regulation of Research Involving Cannabis - The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard

September 20, 2022 @ 2:00 pm 4:00 pm

Virtual Event

As more states move to legalize marijuana, the regulatory landscape is becoming increasingly complex. The number of sponsors and researchers inquiring about these regulations has also increased. Clinical research involving cannabis is subject to both federal and state regulations. Key regulatory frameworks include DEA regulations on the use of controlled substances in research studies, FDA IND regulations, and state law. Proposed federal legislation may also affect the conduct of research involving cannabis. David Peloquin, MRCT Center Senior Advisor and Partner at Ropes & Gray LLP, provided an overview of DEA and FDA regulations relating to research involving cannabis, reviewed recent legislative developments, and discussed state-level policies and challenges using New York state as an example.


Meeting Summary

Released on: September 20, 2022

Topics: 1) Legal and Regulatory Perspectives of For-Profit Research Sites, and 2) The Regulation of Research Involving Cannabis